Acacia (ACTG -23.7%) crashes following its Q1 report. Though revenue soundly beat estimates (no doubt thanks to recent licensing deals), the EPS beat was relatively narrow thanks to surging expenses. While revenue declined 22% Y/Y, inventor royalty payments rose 143% Y/Y to $18.5M, contingent legals fees 301% to $15M, litigation/licensing expenses 185% to $9.6M (Acacia still expects only $18M-$20M for all of 2013), and patent amortization 129% to $11.7M. Also, during the earnings call, Acacia stated it's "deploying more capital in the form of upfront advances" for patent deals, which it recaptures when initial revenue is collected. [View news story]
Thank you for nothing. I see in this short article that you agree (in a backhanded way) that you used the wrong EPS comparison yesterday in your alert. Oh, you published my comment 3 hours later after no one was looking. The stock beat both earnings and revenue and you helped me lose $7000 on my 1000 shares today. I wish there was a way for me to recover damages from your incorrect reporting. It also shows that analyst reporting means more to consumers that anything the comany really reports. At least get it right next time. Again, thanks for losing my money. Be much more careful in the future. An unhappy alert-getter. Gary Rehm, and I am always logged in as GARY0346.
Acacia Research (ACTG): Q1 EPS of $0.47 beats by $0.05. Revenue of $76.8M beats by $18.12M. Shares -0.1% AH. (PR) [View news story]
I do not understand the earnings comparison. What I find for analyst expectation for the quarter is $.423 on several sites. Is this not correct? If I am correct then you should republish your statement.
Dycom Industries (DY): Q3 EPS of $0.36 beats by $0.02. Revenue of $323M beats by $10M. (PR) [View news story]
I live off of my investments on a moderate-size protfolio - about 500K and my expenses are about 6K per month so I need to make good decisions. I think that DY is one of them.
Acacia (ACTG -23.7%) crashes following its Q1 report. Though revenue soundly beat estimates (no doubt thanks to recent licensing deals), the EPS beat was relatively narrow thanks to surging expenses. While revenue declined 22% Y/Y, inventor royalty payments rose 143% Y/Y to $18.5M, contingent legals fees 301% to $15M, litigation/licensing expenses 185% to $9.6M (Acacia still expects only $18M-$20M for all of 2013), and patent amortization 129% to $11.7M. Also, during the earnings call, Acacia stated it's "deploying more capital in the form of upfront advances" for patent deals, which it recaptures when initial revenue is collected. [View news story]
Acacia Research (ACTG): Q1 EPS of $0.47 beats by $0.05. Revenue of $76.8M beats by $18.12M. Shares -0.1% AH. (PR) [View news story]
Gary Rehm
Dycom Industries (DY): Q3 EPS of $0.36 beats by $0.02. Revenue of $323M beats by $10M. (PR) [View news story]
Dycom Industries (DY): Q3 EPS of $0.36 beats by $0.02. Revenue of $323M beats by $10M. (PR) [View news story]